eScholarship
metadata only
CC BY-NC-ND
Synergistic FRET assays for drug discovery targeting RyR2 channels
A key therapeutic target for heart failure and arrhythmia is the deleterious leak through sarcoplasmic reticulum (SR) ryanodine receptor 2 (RyR2) calcium release channels. We have previously developed methods to detect the pathologically leaky state of RyR2 in adult cardiomyocytes by monitoring RyR2
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- β-Adrenergic control of sarcolemmal CaV1.2 abundance by small GTPase Rab proteins#1298595
- Comparison of Focal Cryoablation vs. Radiofrequency Cardioneuroablation for Bradyarrhythmias#1245797
- Cadherin 2-Related Arrhythmogenic Cardiomyopathy#268623
- Computational models for predictive cardiac ion channel pharmacology#1373278
- Aberrant myocardial calcium cycling: pathogenic mechanisms and targeted therapeutics for heart failure.#1054179
Record · ID 1249926
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive